RITUXIMAB — all Canadian products
9 DINs
8 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is RITUXIMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02565781 | ADRUXE | DR. REDDY'S LABORATORIES SA | Solution | Intravenous | RITUXIMAB 10 MG | Approved | |
| 02241927 | RITUXAN | HOFFMANN-LA ROCHE LIMITED | Solution | Intravenous | RITUXIMAB 10 MG | Marketed | |
| 02473976 | RITUXAN SC | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous | RITUXIMAB 1600 MG | Marketed | |
| 02457350 | RITUXAN SC | HOFFMANN-LA ROCHE LIMITED | Solution | Subcutaneous | RITUXIMAB 1400 MG | Marketed | |
| 02498316 | RIXIMYO | SANDOZ CANADA INCORPORATED | Solution | Intravenous | RITUXIMAB 10 MG | Marketed | |
| 02495724 | RUXIENCE | PFIZER CANADA ULC | Solution | Intravenous | RITUXIMAB 10 MG | Marketed | |
| 02478390 | TRUXIMA | CELLTRION INC. | Solution | Intravenous | RITUXIMAB 500 MG | Marketed | |
| 02478382 | TRUXIMA | CELLTRION INC. | Solution | Intravenous | RITUXIMAB 100 MG | Marketed | |
| 02513447 | RIABNI | AMGEN CANADA INC | Solution | Intravenous | RITUXIMAB 10 MG | Cancelled Post Market |
Browse other molecules: